Dan Recht, widely recognized as one of Denver’s best criminal defense lawyers, retired from the private practice of law as of January 1, 2021. DENVER, COLORADO, UNITED STATES, January 4, 2021 /EINPresswire.com/ -- January 4, 2021 Denver, Colorado …
Utilities Purchasing Electro Scan Equipment for ‘Self-Testing’ CIPP Grew 60% in 2020 SACRAMENTO, CALIFORNIA, USA, January 4, 2021 /EINPresswire.com/ -- Electro Scan Inc. announced results from its Fifth Annual Survey of Cured-In-Place Pipe (CIPP) …
BOSTON, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that securities class actions have been filed against Interface, Inc. (NASDAQ: TILE), JOYY, Inc. (NASDAQ: YY …
NEW YORK, Jan. 04, 2021 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. and Levi & Korsinsky, LLP announce that the United States District Court for the Southern District of New York has approved the following announcement of a proposed class action …
WATERTOWN, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, …
NEWTON, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and …
SAN FRANCISCO, Jan. 04, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today …
REDWOOD CITY, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that management will …
ISELIN, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release financial results for the quarter and year ended December 31, 2020 on Friday, January 29, 2021 at approximately 8:00 a.m. ( …
GAITHERSBURG, Md., Jan. 04, 2021 (GLOBE NEWSWIRE) -- UltiSat, a leading systems integrator and communications services provider to the defense, federal civilian, humanitarian-aid, and critical infrastructure markets, announced today the realignment of its …
SAN DIEGO, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security Solutions provider, announced today that Kratos’ Microwave Electronic Products Division (KMED) has recently received a …
FS222 is a potentially best-in-class bispecific antibody targeting CD137 (4-1BB) and PD-L1, and is the Company’s third bispecific to enter clinical trials Preclinical studies demonstrated potent clustering and activation of CD137 by FS222 that is …
NEW YORK, Jan. 04, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Ideanomics (NASDAQ: IDEX) today announces that it has been featured in a broadcast via NetworkNewsAudio (NNA), a solution that delivers additional visibility, recognition and brand awareness in …
Vancouver, B.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- (Vancouver, Canada January 4th, 2021) Lomiko Metals Inc. (“Lomiko”) (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) has monitored news from Automakers in 2020 which indicates a strong trend toward Electric Vehicle (EV …
MARYSVILLE, Ohio, Jan. 04, 2021 (GLOBE NEWSWIRE) -- To support the rise in gardening nationwide and address the critical need to connect more children to healthy food, The Scotts Miracle-Gro Foundation today opened its GroMoreGood Grassroots Grants with …
MARIETTA, Ga., Jan. 04, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, Chief Executive Officer, …
-Phase 1a trial achieved primary objective of safety and tolerability -PT101 induced potent and selective expansion of regulatory T cells exceeding levels associated with clinical benefit in third-party clinical trials across multiple autoimmune diseases - …
KANSAS CITY, Mo., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Today, millions of Americans will receive a second stimulus payment as the IRS set January 4 as the official payment date of all direct deposits for stimulus money. The IRS has shared that most people …
VANCOUVER, British Columbia, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Siyata Mobile Inc. (NasdaqCM: SYTA, SYTAW) (“Siyata” or the “Company”) is pleased to announce that it has closed a private placement in Israel and Canada of 129,450 units of the Company (the “ …
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, today announced the …
02 days 04:07:38
